Program
10:00 – 10:10 |
Presentation
Gustavo Quintero Hernández, MD, MSc. Dean, School of Medicine and Health Sciences, Rosario University, Bogotá |
10:10 – 10:30 | Clinical trials during the Pandemic. On the importance of research and the role of INVIMA
Julio C. Aldana, MD. Director General of the National Institute for Food and Drug Surveillance (INVIMA), Bogotá |
10:30 – 10:50 | PC-COVID-19 study. Final results.
Rubén Manrique, PhD CES University, Medellín Researcher Group PC-COVID-19 |
10:50 – 11:10 | Safety and efficacy of convalescent plasma in COVID-19. What do the meta-analyzes show?
Manuel Rojas, MD, MSc CREA, University of Rosario Researcher Group PC-COVID-19 |
11:10 – 11:30 | Mechanisms of action of convalescent plasma
Yenny Acosta, PhD CREA, Universidad del Rosario, Bogotá Researcher Group PC-COVID-19 |
11:30 – 12:00 | Discussion. |
Moderator: Juan Manuel Anaya, director of the Center for Studies of Autoimmune Diseases ( Create ) of the Universidad del Rosario.